Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
People channel feed
Esperion's CMO hits the exit; Pfizer appoints Nvidia alum as AI chief
10 months ago
Peer Review
Genentech dissolves cancer immunology group, and research executive Ira Mellman will leave company
10 months ago
Pharma
Updated: Lykos cutting most of staff less than a week after FDA rejection
10 months ago
FDA+
Acelyrin sheds pipeline, lays off 33% of staff three months after CEO departure
11 months ago
R&D
Lilly opens huge new Boston research center, with a focus on genetic medicines
11 months ago
R&D
Pharma
Lexicon cuts about 75 sales jobs to prep for drug launch early next year
11 months ago
Pharma
Bill Haney's Dragonfly nabs former Cerevel CFO; Cellectis' new CMO
11 months ago
Peer Review
Infectious disease biotech undergoes makeover after lung disease trial underwhelms
11 months ago
R&D
Q&A: PhRMA CEO Stephen Ubl on the IRA, challenges to the FDA’s authority and the US-China relationship
11 months ago
Pharma
Entero Therapeutics turns the lights off as creditors come calling
11 months ago
Precigen lays off staff, pauses multiple CAR-T programs and all preclinical work and aims for $30M offering
11 months ago
R&D
Bicycle Therapeutics focuses pipeline and streamlines leadership team
11 months ago
R&D
Exclusive: Covid and epidemic threat biotech Aerium Therapeutics closes after emergence of variants
11 months ago
Startups
Coronavirus
Exclusive: Biotech investor Sofinnova hires former Biogen medical chief
11 months ago
Bristol Myers to cut more jobs at headquarters as part of announced restructure
11 months ago
Pharma
Q&A: Genentech's new CEO on AI, IRA and radiopharma
11 months ago
R&D
AI
Florida CNS gene therapy biotech shuts down
11 months ago
Startups
Cell/Gene Tx
PARP biotech backed by more than five pharmas closes after nine years
11 months ago
Startups
Former RayzeBio CEO quickly returns with new biotech; Amgen’s global research leader steps down
11 months ago
Peer Review
Despite recent trial success, uniQure plans to cut 65% of staff
11 months ago
Pharma
Arbutus reduces headcount after axing HBV combo trial that features Imfinzi
11 months ago
R&D
Updated: Jim Wilson to step down from gene therapy post at UPenn, will form two new companies
11 months ago
R&D
Cell/Gene Tx
After norovirus vaccine's trial failure, HilleVax lays off 40% of staff
11 months ago
FibroGen to shrink US workforce by 75% following more late-stage fails
11 months ago
R&D
First page
Previous page
8
9
10
11
12
13
14
Next page
Last page